Application of penicillium roqueforti pr1 secondary metabolites and effective components in prevention and treatment of plant bacterial diseases
By preparing and purifying ethyl-α-D-glucoside and ethyl-β-D-glucopyranoside from the secondary metabolites of Penicillium erythropoiesisrum PR1, and using them as plant immune inducers, the problem of limited efficacy in the control of bacterial diseases in plants in existing technologies has been solved, and efficient and safe disease control has been achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANDONG PENGBO BIOTECHNOLOGY CO LTD
- Filing Date
- 2026-05-08
- Publication Date
- 2026-07-21
AI Technical Summary
Existing chemical control methods have limited effectiveness in controlling bacterial plant diseases, and there are problems with pesticide residues and environmental pollution. Furthermore, the application of existing plant immune inducers is limited, making it difficult to meet the needs for green, safe, and effective control.
Secondary metabolites of Penicillium erythropoiesis-producing strain PR1 and its active ingredients ethyl-α-D-glucoside and ethyl-β-D-glucopyranoside were used as plant immune inducers. Through preparation and purification processes, highly efficient and safe control components were obtained for the control of bacterial diseases such as bacterial leaf blight in rice.
It significantly improved the plant's resistance to bacterial diseases by inducing the activity of enzymes related to plant defense responses and the expression of salicylic acid signaling pathway, thereby enhancing the plant's disease resistance and achieving efficient and safe disease control.
Smart Images
Figure CN122139755B_ABST